Sanofi-Aventis
Sanofi-Aventis (pronunciation: /sæˈnoʊfi əˈvɛntɪs/) is a multinational pharmaceutical company that focuses on researching, developing, manufacturing, and marketing pharmaceutical products globally. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011.
Etymology
The name "Sanofi-Aventis" is derived from the names of the two merging companies. "Sanofi" comes from "Sanofi-Synthélabo", which in turn was named after the French pharmaceutical company Synthélabo, and "Aventis" originates from the company Aventis Pharma, a subsidiary of Hoechst AG, a German chemical company that merged with Rhône-Poulenc in 1999.
Operations
Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).
Related Terms
- Pharmaceutical industry
- Pharmaceutical research
- Clinical trial
- Drug discovery
- Drug development
- Pharmacology
- Pharmacokinetics
- Pharmacodynamics
This WikiMD.org article is a stub. You can help make it a full article.